Welcome to our dedicated page for Surgery Partners news (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.
Surgery Partners, Inc. reports developments tied to its short-stay surgical facility network and outpatient delivery model. The company provides surgical and related ancillary care through ambulatory surgery centers, surgical hospitals, anesthesia services, multi-specialty physician practices and urgent care facilities, with revenue tied to patient care services and facility case activity.
Recurring SGRY news includes quarterly results, same-facility revenue and case trends, adjusted EBITDA and guidance, operational initiatives, portfolio optimization, acquisition activity, financing and leverage actions, share repurchase authorizations, board composition and shareholder communications involving the company’s strategic direction.
Surgery Partners (NASDAQ:SGRY) and Baylor Scott & White Health formed a joint venture announced Dec 08, 2025 to jointly own the 16-bed Physicians Centre Hospital in Bryan, Texas.
The hospital will operate under the Baylor Scott & White name while Surgery Partners will continue day-to-day management. Patients can keep current providers. Services include bariatric, ophthalmologic, oral/maxillofacial, orthopedic, GI, podiatric, spinal, urologic, general, plastic/reconstructive surgery, sports medicine, pain management and radiology.
Surgery Partners (NASDAQ:SGRY) reported third quarter 2025 results for the period ended September 30, 2025. Revenue was $821.5 million, up 6.6% YoY; same-facility revenue rose 6.3%. Adjusted EBITDA was $136.4 million, up 6.1% YoY, while net loss attributable was $22.7 million. Year-to-date revenue was $2,423.7 million, up 7.7%, with YTD Adjusted EBITDA of $369.3 million. Liquidity included $203.4 million cash and $405.9 million revolver capacity. Leverage was ~4.2x net debt/EBITDA and 4.6x consolidated debt/Adj EBITDA. Full-year 2025 guidance: $3.275–3.30 billion revenue and $535–540 million Adjusted EBITDA.
Management noted softer-than-expected volume and payor mix and delayed capital deployment as drivers of a prudent fourth-quarter outlook.
Surgery Partners (NASDAQ:SGRY) will release its third quarter 2025 results before the market opens on Monday, November 10, 2025, followed by a conference call at 8:30 a.m. ET.
Live dial-in numbers: 1-877-451-6152 (domestic) and 1-201-389-0879 (international). A replay will be available three hours after the call until November 24, 2025 at 1-844-512-2921 (domestic) and 1-412-317-6671 (international). Passcode for live and replay: 13756022. A simultaneous webcast and replay will be available on the company Investor Relations website at www.surgerypartners.com.
Surgery Partners (NASDAQ:SGRY) reported strong Q2 2025 financial results, with revenue increasing 8.4% to $826.2 million and Adjusted EBITDA growing 9.0% to $129.0 million. Same-facility revenues rose 5.1%, driven by a 3.4% increase in cases and 1.6% growth in revenue per case.
The company reaffirmed its full-year 2025 guidance, projecting revenue between $3.30-3.45 billion and Adjusted EBITDA of $555-565 million. Surgery Partners maintained strong liquidity with $250.1 million in cash and $394.9 million available under its revolving credit facility, while operating cash flow was $81.3 million for Q2 2025.
Surgery Partners (NASDAQ:SGRY), a leading short-stay surgical facility operator, has scheduled its second quarter 2025 earnings release for Tuesday, August 5, 2025, before market open. The company will host a conference call at 8:30 a.m. Eastern Time to discuss the results.
Investors can access the call via phone (1-844-826-3033 domestic, 1-412-317-5185 international) or through a simultaneous webcast on the Investor Relations section of Surgery Partners' website. A replay will be available for two weeks until August 19, 2025, using passcode 10201328.
Surgery Partners (NASDAQ:SGRY) has scheduled its first quarter 2025 earnings release and conference call. The company will release Q1 2025 results before market open on Monday, May 12, 2025, followed by a conference call at 8:30 a.m. Eastern Time.
Investors can access the live call via phone at 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available for two weeks until May 26, 2025, accessible at 1-844-512-2921 (domestic) or 1-412-317-6671 (international) using passcode 13752904.
A simultaneous webcast will be available on the Investor Relations section of Surgery Partners' website at www.surgerypartners.com, where the replay will also be accessible.
Surgery Partners (NASDAQ:SGRY) reported strong financial results for Q4 and full year 2024. Revenue increased 17.5% to $864.4M in Q4 and 13.5% to $3.1B for the full year. Same-facility revenues grew 5.6% in Q4 and 8.0% for 2024.
The company posted Q4 Adjusted EBITDA of $163.8M, up 15.1%, and full-year Adjusted EBITDA of $508.2M, a 16.0% increase. However, net losses were $108.5M for Q4 and $168.1M for 2024.
For 2025, Surgery Partners projects revenue between $3.30B-$3.45B and Adjusted EBITDA of $555M-$565M. The company maintains strong liquidity with $269.5M cash and $501.5M in credit facility availability. Operating cash flows improved to $111.4M in Q4 2024 from $62.6M in Q4 2023.
Surgery Partners (NASDAQ:SGRY), a leading short-stay surgical facility operator, has scheduled its fourth quarter 2024 earnings release for Monday, March 3, 2025, before market open. The company will host a conference call at 8:30 a.m. Eastern Time on the same day.
Participants can access the call via phone using 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available for two weeks until March 17, 2025, accessible at 1-844-512-2921 (domestic) or 1-412-317-6671 (international) using passcode 13751533. A simultaneous webcast will be available on the Investor Relations section of the company's website.